Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Industry Aims To Prevent Image Problems That Have Plagued Pharma

This article was originally published in The Gray Sheet

Executive Summary

Recent polling data commissioned by AdvaMed suggest that medical devices, if not the industry itself, are still in relative good graces with the public, but that clear vulnerabilities exist
Advertisement

Related Content

PhRMA CEO: Ubl Pick Brings User Fee, Reimbursement Expertise
PhRMA CEO: Ubl Pick Would Bring User Fee, Reimbursement Expertise
AdvaMed Launches National Search For New CEO As Ubl Plans Departure
It’s The Economy, Stupid: “Value” Campaign To Stress System-Wide Savings
It’s The Economy, Stupid: “Value” Campaign To Stress System-Wide Savings
SEC-Like Agency Would Bring Transparency To Healthcare – Herzlinger
SEC-Like Agency Would Bring Transparency To Healthcare – Herzlinger
AdvaMed Escalates Opposition To Inpatient Proposal With Ad Campaign
Cardiac Rhythm Management Firms Targeted By DoJ Fraud Investigation
Cardiac Rhythm Management Firms Targeted By DoJ Fraud Investigation
Advertisement
UsernamePublicRestriction

Register

MT023286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel